<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Arnold, Justice</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Impact of Depression on Fibromyalgia Treatment — Selected Posters</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-13</style></pages><abstract><style  face="normal" font="default" size="100%">Fibromyalgia is a chronic disorder that affects approximately 3.4% of women and 0.5% of men in the United States. It is characterized as widespread musculoskeletal pain, fatigue, and a reduced threshold for pain. Treatment can be complicated by the comorbid depressive moods that often accompany fibromyalgia. Three double-blind, placebo-controlled studies examined the correlation between treatment effect on pain and levels of depression/anxiety in fibromyalgia patients.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>